1700016G22Rik Activators
1700016G22Rik Activators represent a diverse set of chemical compounds that indirectly promote the functional activity of 1700016G22Rik through specific biochemical pathways. Forskolin, Isoproterenol, and Dibutyryl cAMP work by increasing intracellular cAMP levels, thereby activating PKA, which could phosphorylate 1700016G22Rik or proteins that regulate its activity, leading to an enhancement of its function. PMA and Sphingosine-1-phosphate target PKC and Akt pathways respectively, which can also result in the phosphorylation of 1700016G22Rik or its regulatory factors. The alteration of intracellular calcium levels by agents like Ionomycin and Thapsigargin activates calcium-dependent kinases, which might then enhance the functionality of 1700016G22Rik. Epigallocatechin gallate, by inhibiting certain kinases, and Staurosporine, despite being a broad inhibitor, could allow for the upregulation of 1700016G22Rik activity by reducing competitive phosphorylation or by lifting inhibitory controls on associated signaling pathways.
In addition to these mechanisms, LY294002 and U0126, by inhibiting PI3K and MEK1/2 respectively, may shift cellular signaling dynamics to favor the activation of 1700016G22Rik through alternative pathways. Retinoic acid, by modulating gene expression, could upregulate proteins that interact with or regulate 1700016G22Rik, thereby enhancing its activity. Collectively, these chemicals exploit various signaling cascades such as cAMP/PKA, PKC, Akt, calcium signaling, and kinase inhibition to potentiate the activity of 1700016G22Rik. The specificity of these pathways ensures that the activation of 1700016G22Rik is precisely targeted, resulting in the enhancement of its functional role in cellular processes without affecting the general protein expression or activating non-specific pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analog that activates protein kinase C (PKC). Activation of PKC can lead to phosphorylation of downstream proteins that may interact with or regulate 1700016G22Rik, resulting in the enhancement of 1700016G22Rik activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. The rise in calcium can activate calcium-dependent protein kinases, which may phosphorylate and enhance 1700016G22Rik or associated regulatory proteins. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol that inhibits certain types of protein kinases. Inhibition of competitive kinases may result in the upregulation of 1700016G22Rik's activity by shifting the balance of phosphorylation towards pathways that activate 1700016G22Rik. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P binds to its G-protein-coupled receptors, initiating signaling cascades that can lead to the activation of protein kinase B (Akt). Akt can phosphorylate a variety of substrates that may include 1700016G22Rik or its regulators, enhancing 1700016G22Rik's activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which can lead to the activation of alternative pathways that might enhance the activity of 1700016G22Rik, assuming 1700016G22Rik's function is upregulated when PI3K/Akt signaling is downregulated. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to an increase in cytosolic calcium. Elevated calcium levels can activate calcium-dependent signaling pathways, possibly leading to the enhancement of 1700016G22Rik's activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid regulates gene expression through its nuclear receptors. It can influence signaling pathways that may enhance the activity of 1700016G22Rik by modulating the transcription of genes encoding proteins that interact with or regulate 1700016G22Rik. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
db-cAMP is a cAMP analog that can permeate cell membranes and directly activate PKA. Activated PKA may phosphorylate and enhance 1700016G22Rik if it is a direct or indirect target of PKA. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor. By inhibiting certain kinases, it might lead to the selective activation of pathways that enhance 1700016G22Rik activity by alleviating negative regulatory effects on 1700016G22Rik or its associated pathways. | ||||||